ABSTRACT
The novel coronavirus SARS-CoV-2 is a positive single-stranded RNA virus that can be immediately translated and integrated into the host cell with its own RNA messenger, facilitating replication inside the cell and infectivity. The rapid progression of the disease presents a real challenge for the whole world. As the usual capacity for citizen care is exceeded, health professionals and governments struggle. One of the most important strategies to reduce and mitigate the advance of the epidemic are social distance measures; this is where telemedicine can help, and provide support to the healthcare systems, especially in the areas of public health, prevention and clinical practices, just as it is doing in others sectors. Telemedicine connects the convenience, low cost, and ready accessibility of health-related information and communication using the Internet and associated technologies. Telemedicine during the coronavirus epidemic has been the doctors' first line of defense to slow the spread of the coronavirus, keeping social distancing and providing services by phone or videoconferencing for mild to focus personal care and limited supplies to the most urgent cases.
Subject(s)
Betacoronavirus , Coronavirus Infections , Pandemics , Pneumonia, Viral , Telemedicine/methods , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Global Health , Humans , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , SARS-CoV-2ABSTRACT
La primera causa de mortalidad en los niños después del primer año de vida son los tumores malignos. La supervivencia global es del 80% a los cinco años. La calidad de vida de los niños que sobreviven a un proceso oncológico puede verse alterada por la toxicidad del sistema nervioso central, causada por el mismo cáncer y por el tratamiento realizado. Presentamos un caso clínico de la afectación neuropsicológica en un niño con cáncer y su abordaje
Malignant tumors are the first cause of mortality in children after the first year of life. Global survival is 80% at 5 years. Quality of life of the children that survives an oncology process can be impaired by neurotoxicity of the nervous central system, caused by the treatment of cancer. We report a clinic case of the neuropsychological deficit in a child with cancer and its clinical approach
